CD274 and acute myeloid leukemia: One approach is the signal transducer and activator of transcription 5 (STAT5), which promotes PD-L1 expression by facilitating histone lactylation and driving immunosuppression in AML and thus may benefit from PD-1/PD-L1 immunotherapy.